SS-31: The Mitochondrial Protection Peptide
SS-31 is unusual in the peptide field because it has something most research peptides do not: FDA clinical trials. The […]
SS-31 is unusual in the peptide field because it has something most research peptides do not: FDA clinical trials. The […]
The most common question in metabolic medicine right now is which of these two drugs to start with, and the
The GLP-1 category has evolved through three generations in less than a decade, and each generation represents a different approach
Semaglutide hits one receptor. Tirzepatide hits two. Retatrutide hits three, and the third one does something the first two cannot
NAD+ has become one of the most discussed compounds in longevity medicine, and the debate over how to take it
A ranked analysis of the top five longevity peptides based on mechanism strength, evidence depth, and effect size. GLP-1 agonists may surprise you.
GLP-1 drugs are the most important metabolic intervention in a generation, and semaglutide, tirzepatide, and retatrutide work through three different
Most longevity advice asks you to chase molecules. The smarter move is to understand the conversation your cells are already
Small daily habits compound into significant healthspan gains. Here are three science-backed practices to start today.
Aging is not fixed. Researchers now know how to target the root biological processes that drive decline and disease.